APPENDICES - NIHR Health Technology Assessment Programme

148
Appendix 6
carcinomas: 5 years experience.] Nederland Tijdschr
Dermatol Venereol 2004;14:307–13.
196. Thompson MS, Andersson-Engels S, Svanberg
S, Johansson T, Palsson S, Bendsoe N, et al.
Photodynamic therapy of nodular basal cell
carcinoma with multifiber contact light delivery.
J Environ Pathol Tox 2006;25:411–24.
197. Tindholdt TT, Tonseth KA, Bjaerke TK, Abyholm
FE. [Photodynamic therapy of facial basal cell
carcinoma.] Tidsskr Nor Laegeforen 2007;127:
1928–30.
198. Tobola J, Witkowska A, Ostrowski J, Kucharczyk
Z. [Topical treatment of superficial basal cell
carcinomas with 5% 5-fluorouracil ointment.] Przegl
Dermatol 2003;90:357–62.
199. Toll A, Parera Ma E, Velez M, Pujol RM.
Photodynamic therapy with methyl aminolevulinate
induces phototoxic reactions on areas of the nose
adjacent to basal cell carcinomas and actinic
keratoses. Dermatol Surg 2008;34:1145–7.
200. Toll A, Parera ME, Velez M, Pujol RM. Letter:
photodynamic therapy with methyl aminolevulinate
induces phototoxic reactions on areas of the nose
adjacent to basal cell carcinomas and actinic
keratoses. Dermatol Surg 2008;34:1145–7; discussion
7–8.
201. Tomio L, Corti L, Polico C, Maluta S, Calzavara
F, Norberto L, et al. [Laser-photo-radiotherapy
in the treatment malignant tumors.] Radiol Med
1987;73:313–16.
202. Tope WD, Ross EV, Kollias N, Martin A,
Gillies R, Anderson RR. Protoporphyrin IX
fluorescence induced in basal cell carcinoma by
oral delta-aminolevulinic acid. Photochem Photobiol
1998;67:249–55.
203. Tosca AD, Balas CJ, Stefanidou MP, Katsantonis
JC, Georgiou S, Tzardi MN, et al. Prediction of
ALA-PDT efficacy through remote color inspection
and post therapy sequential histologic observations
of skin malignancies. SPIE Proceedings Series
1997;3191:221–30.
204. Tse DT, Kersten RC, Anderson RL.
Hematoporphyrin derivative photoradiation
therapy in managing nevoid basal-cell carcinoma
syndrome. A preliminary report. Arch Ophthalmol
1984;102:990–4.
205. Umegaki N, Moritsugu R, Katoh S, Harada
K, Nakano H, Tamai K, et al. Photodynamic
therapy may be useful in debulking cutaneous
lymphoma prior to radiotherapy. Clin Exp Dermatol
2004;29:42–5.
206. Usmani N, Telfer NR, Stables GI. Subungual
Bowen’s disease treated by topical photodynamic
therapy. Br J Dermatol 2004;151:96.
207. Vaicova M, Ettler K. [Our clinical experience
with the use of photodynamic therapy in patients
with the basal cell carcinoma and morbus Bowen
(comparison of efficacy of two photosensitizers).]
Cesk Dermatol 2004;79:200–4.
208. Vakoulovskaia E, Chental V, Kuvshinov Y,
Poddubny B, Ivanov AV, Kazaryan MA. New
approaches to photodynamic therapy of tumors
with Al phthalocyanine. SPIE Proceedings Series
2000;4059:32–8.
209. Vakulovskaya EG, Kemov YV, Zalevsky ID,
Reshetnikov AV, Umnova LV, Vorozhcsov GN.
Photodynamic therapy and fluorescent diagnostics
of skin cancer with radochlorine and photosense,
comparing efficacy and toxicity. SPIE Proceedings
Series 2004;5315:148–51.
210. Van de Mierop F, Lightdale CJ. Use of atropine
during endoscopy: benefit during photodynamic
therapy. Gastrointest Endosc 1996;44:512.
211. Van Oosten EJ, Kuijpers DIM, Thissen MRTM.
Different pain sensations in photodynamic therapy
of nodular basal cell carcinoma: results from a
prospective trial and a review of the literature.
Photodiag Photodyn Ther 2006;3:61–8.
212. Varma S, Anstey A, Wilson H, Kurwa HA.
Photodynamic therapy for the treatment of Bowen’s
disease, solar keratoses, and superficial basal cell
carcinomas: 12 months experience with a novel
light source. Br J Dermatol 1998;139:19.
213. Varma S, Wilson H, Kurwa HA, Charman C.
One year relapse rates for Bowen’s disease, basal
cell carcinomas and solar keratoses treated by
photodynamic therapy: analysis of 189 lesions. Br J
Dermatol 1999;141:114–18.
214. Varma S, Wilson H, Kurwa HA, Gambles B,
Charman C, Pearse AD, et al. Bowen’s disease, solar
keratoses and superficial basal cell carcinomas
treated by photodynamic therapy using a largefield
incoherent light source. Br J Dermatol
2001;144:567–74.
215. Vinciullo C, Elliott T, Francis D. MAL-PDT
in “difficult-to-treat” basal cell carcinoma, an
Australian study: 48 month follow-up data. J Invest
Dermatol 2006;126:S34.
216. Vinciullo C, Elliott T, Francis D, Gebauer K,
Spelman L, Nguyen R, et al. Photodynamic
therapy with topical methyl aminolaevulinate for
‘difficult-to-treat’ basal cell carcinoma. Br J Dermatol
2005;152:765–72.